Targeted Metallo-Drugs: Design, Development, and Modes of Action (Metal Ions in Life Sciences Series)

Targeted Metallo-Drugs: Design, Development, and Modes of Action (Metal Ions in Life Sciences Series)

6 $

Format : Publisher PDF

File Size : 27.4 MB

Category:

Targeted Metallo-Drugs: Design, Development, and Modes of Action (Metal Ions in Life Sciences Series)

By Etelka Farkas, Celine J. Marmion

By Etelka Farkas, Celine J. Marmion

Volume 24 of the series Metal Ions in Life Sciences (MILS) delves into the exciting field of Targeted Metallo-Drugs: Design, Development, and Modes of Action. This volume brings together the expertise of 32 international experts from Europe, Asia, and North and South America to provide comprehensive and cutting-edge insights into the development and potential of metallo-drugs for therapeutic exploitation.

Over the years, the clinical success of cisplatin as a frontline anticancer drug has been marred by its dose-limiting toxic side effects and the emergence of drug resistance. In response, scientists worldwide have made great strides in identifying new metallo-drugs that address these challenges. The latest breakthroughs in this field are captured in MILS-24, featuring 12 meticulously crafted chapters with over 1600 citations, 100 figures, and 10 tables. The book offers a wealth of new knowledge and serves as a vital resource for researchers, clinicians, and students interested in advancing the design and development of targeted metallo-drugs.

One of the main driving forces behind the research into metallo-drugs is the quest for enhanced cancer cell selectivity and reduced toxic side effects. MILS-24 showcases the progress made in this area, highlighting metallo-drug candidates that demonstrate better selectivity, minimizing harm to healthy cells while targeting cancerous cells more effectively. By exploring new modes of action, these metallo-drugs also offer the potential to improve efficacy and tackle resistance pathways that often hinder conventional therapies.

Moreover, MILS-24 goes beyond cancer treatment and explores the development of metallo-drugs for other infectious diseases. With chapters on antimicrobial, antiviral, and tropical disease-targeting agents, as well as cyanide poisoning and radiometals in molecular imaging and therapy, the book provides a comprehensive overview of the diverse applications of metallo-drugs in biomedical research.

One particularly exciting aspect of MILS-24 is its coverage of recent developments in metallo-drugs that target COVID-19. As the world continues to grapple with the ongoing pandemic, the importance of effective antiviral therapies cannot be overstated. With insights from experts in the field, this volume offers valuable perspectives on the potential of metallo-drugs in combating viral infections, including SARS-CoV-2.

Advanced spectroscopic methods and metallomics play a crucial role in elucidating the modes of action of metallo-drugs. MILS-24 recognizes the significance of these techniques and features in-depth discussions on their utility in understanding how metallo-drugs interact with biological systems and exert their therapeutic effects.

For those interested in staying up to date with the latest developments in the field of targeted metallo-drug design and development, MILS-24 is an indispensable resource. The book not only presents the current state of research but also serves as a catalyst for further exploration and innovation in this rapidly evolving field. Its insights and findings will undoubtedly inspire scientists, educate students, and guide clinicians in their quest to develop safer and more effective treatments for cancer and other diseases.

Published by CRC Press, the first edition of MILS-24 is set to be released on May 15, 2023. The book is available as an eBook with 370 pages of invaluable content. With its comprehensive coverage and contributions from leading experts in the field, MILS-24 promises to be an essential addition to any researcher’s or professional’s library.

Product Details

  • Publisher: CRC Press; 1st edition (May 15, 2023)
  • Language: English
  • eBook Digital: 370 pages
  • ISBN-10: 1032223308
  • ISBN-13: 978-1032223308

Order your copy of MILS-24 today and embark on an enlightening journey through the world of targeted metallo-drugs. Uncover the latest breakthroughs, explore new avenues of cancer treatment, and gain valuable insights into the potential of metallo-drugs in combating infectious diseases. With MILS-24 in your hands, you’ll have access to a wealth of knowledge that will undoubtedly shape the future of biomedical research and healthcare.

Product Details

  • It covers anticancer, antimicrobial, antiviral, and other agents, such as those targeting tropical diseases and cyanide poisoning and radiometals in molecular imaging and therapy
  • It highlights recent metallo-drug developments targeting COVID-19
  • It features advanced spectroscopic methods and metallomics as important tools to elucidate the modes of actions of metallo-drugs
  • Publisher ‏ : ‎ CRC Press; 1st edition (May 15, 2023)
  • Language ‏ : ‎ English
  • Hardcover ‏ : ‎ 370 pages
  • ISBN-10 ‏ : ‎ 1032223308
  • ISBN-13 ‏ : ‎ 978-1032223308

Related Products